Split History
ETFs Holding RXII »    RXII Historical Stock Prices »

Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
RXi Pharmaceuticals is a clinical-stage company developing therapeutics based on its self-delivering RNAi (sd-rxRNA®) platform and Samcyprone™, a topical immunomodulator. Co.'s clinical development programs include RXI-109, an sd-rxRNA for the treatment of dermal and ocular scarring, and Samcyprone™, for the treatment of warts. Co.'s development programs also include cell-based cancer immunotherapy. Co.'s RNAi therapies are designed to silence, or down-regulate, the expression of a specific gene that may be over-expressed in a disease condition and its topical immunotherapy agent, Samcyprone™, treats diseases by inducing, enhancing or suppressing an immune response in the skin. According to our RXII split history records, RXII has had 2 splits.
RXII split history picture
RXII (RXII) has 2 splits in our RXII split history database. The first split for RXII took place on April 18, 2016. This was a 1 for 10 reverse split, meaning for each 10 shares of RXII owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. RXII's second split took place on January 08, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of RXII owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 10 share position following the split.

When a company such as RXII conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the RXII split history from start to finish, an original position size of 1000 shares would have turned into 10 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into RXII shares, starting with a $10,000 purchase of RXII, presented on a split-history-adjusted basis factoring in the complete RXII split history. RXII split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 11/16/2018
Start price/share: $399.00
End price/share: $0.33
Dividends collected/share: $0.00
Total return: -99.92%
Average Annual Total Return: -78.82%
Starting investment: $10,000.00
Ending investment: $8.27
Years: 4.57
Date Ratio
04/18/20161 for 10
01/08/20181 for 10
RXII is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

SAY Split History
SBS Split History
SCAI Split History
SCLN Split History
SCYX Split History
SELB Split History
SEM Split History
SGNL Split History
SGYP Split History
SIEN Split History

Also explore: RXII shares outstanding history

Email EnvelopeFree RXII Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Smart for Life, Inc. (SMFL)
Windtree Therapeutics, Inc. (WINT)
Golden Sun Health Technology Group Limited (GSUN)
Zapp Electric Vehicles Group Limited (ZAPP)
Beneficient (BENF)
MySize, Inc. (MYSZ)
Gorilla Technology Group Inc. (GRRR)
Sunshine Biopharma, Inc. (SBFM)
NFT Ltd. (MI)
WiSA Technologies, Inc. (WISA)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

RXII Insider Buying

RXII Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.